Total submissions: 6
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV004567482 | SCV000261672 | likely benign | Familial adenomatous polyposis 1 | 2023-09-18 | criteria provided, single submitter | clinical testing | |
| Color Diagnostics, |
RCV000584582 | SCV000687109 | likely benign | Hereditary cancer-predisposing syndrome | 2017-07-19 | criteria provided, single submitter | clinical testing | |
| Prevention |
RCV000679082 | SCV000805460 | likely benign | not provided | 2017-03-21 | criteria provided, single submitter | clinical testing | |
| Ambry Genetics | RCV000584582 | SCV001188225 | likely benign | Hereditary cancer-predisposing syndrome | 2018-01-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
| Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000679082 | SCV004220515 | likely benign | not provided | 2023-03-23 | criteria provided, single submitter | clinical testing | |
| Myriad Genetics, |
RCV004567482 | SCV005082026 | benign | Familial adenomatous polyposis 1 | 2024-04-08 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |